Log in
Enquire now
‌

US Patent 10555980 Treatment of

Patent 10555980 was granted and assigned to Vedanta Biosciences on February, 2020 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Vedanta Biosciences
Vedanta Biosciences
0
Current Assignee
Vedanta Biosciences
Vedanta Biosciences
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
105559800
Patent Inventor Names
Yun-Gi Kim0
Jessica Schneider0
Juan Patarroyo0
Shilpa Reddy0
Bernat Olle0
Jason Norman0
Date of Patent
February 11, 2020
0
Patent Application Number
164234870
Date Filed
May 28, 2019
0
Patent Citations
‌
US Patent 10064904 Treatment of
‌
US Patent 10350250 Treatment of clostridium difficile infection
Patent Citations Received
‌
US Patent 11701396 Treatment of
0
Patent Primary Examiner
‌
Mary Maille Lyons
0
Patent abstract

Provided herein are compositions and methods for the treatment or prevention of pathogenic infections.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10555980 Treatment of

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.